Mounjaro is approved to treat type 2 diabetes, and Zepbound is a version approved for weight loss
Results vary, but many patients begin noticing weight loss and appetite changes within the first several weeks of treatment
A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have an antidepressant effect, suggesting that these drugs could one day be used in mental health therapy
If patients are getting really inflammatory acne or cystic or scarring acne, we need to get them on systemic therapies very quickly, Tolkachjov said
Pay as you gono locked-in subscriptions
Here is the honest state of the data: Obesity (Phase 2, randomized controlled trial): the landmark New England Journal of Medicine Phase 2 trial in obesity established both the once-weekly dosing and the escalation approach, and reported the largest average weight reductions seen for a once-weekly agent with the caveat that the reduction had not fully plateaued at 48 weeks